Yantai Zhenghai Biological Technology Co., Ltd. (hereinafter referred to as "the Company") held the tenth meeting of the fourth board of directors on March 29, 2026, and approved the proposal regarding the purchase of directors and senior management liability insurance. To further improve the company's risk management system, reduce operational risks, and ensure that directors, senior management, and relevant responsible personnel fully perform their duties, the company intends to purchase liability insurance for directors and senior management. The specifics are as follows:
300653SZSE
Announcement on the Purchase of Directors and Senior Management Liability Insurance
✨ AI Summary
Yantai Zhenghai Biological Technology Co., Ltd. has approved the purchase of liability insurance for its directors and senior management to enhance risk management and reduce operational risks. The insurance will cover a maximum of RMB 50 million for a period of 12 months, with a premium not exceeding RMB 250,000. The board has authorized management to handle related matters efficiently.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.